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ABBREVIATIONS
AAPH – 2,2’-azobis (2-amidinopropane) dihydrochloride; 
MDR – multidrug resistance; 
MTT – 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide; 
RBCs – red blood cells
INTRODUCTION
Mini kiwi (Actinidia arguta, family Actinidiaceae, type: 
vine), commonly called the hardy kiwi, is a variety from north-
ern China. Leaves of this plant are a rich source of phenolic 
substances, mainly composed of phenolic acids (neochloro-
genic, chlorogenic and cryptochlorogenic acid), B-type pro-
cyanidin dimers, (+) catechin and fl avonols (quercetin glyco-
sides, mostly triglycosides and kaempferol with 1, 2 or 3 sugar 
substituents) [Cyboran et  al., 2014]. The presence of  these 
substances ensures the biological activity, which includes an-
tioxidant activity, hypoglycemic and antiproliferative action, 
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and  support of  the digestive system [Montoya et  al., 2014; 
Zuo et al., 2012].
One of the main causes of many pathological states and ag-
ing of the organism is believed to be disturbance of the oxida-
tion-reduction balance that results in oxidative stress caused 
by a high concentration of free radicals [Kaur et al., 2014]. As 
a consequence, this leads to deterioration of basic life processes 
of  cells, irreversible structural changes, mutations, and  ulti-
mately to cell death [Valko et al., 2007]. Therefore, currently, 
special attention is devoted to substances with high ability to 
reduce free radicals, mostly through looking for compounds 
of plant origin that do not show side effects on the organism.
Erythrocytes (RBC), due to their high content of unsatu-
rated fatty acids and the ability of oxygen transfer [Chai et al., 
2014], are constantly exposed to oxidative stress, which leads to 
changes in physical properties of the cell membrane responsible 
for integrity and mechanical properties of the cells, and conse-
quently hinders their movement, in particular in the blood cap-
illary veins. Oxidative damage occurs not only in membrane 
lipids but also in proteins, e.g. hemoglobin and spectrin, which 
in turn leads to irreversible structural changes and blood cell 
hemolysis [Becker et al., 1986; Buchwald et al., 2000]. The ef-
fect of oxidative stress on the physical properties and physi-
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The leaves of mini kiwi (Actinidia arguta) are a rich source of phenolic compounds, in particular the B-type procyanidins that exhibit e.g. antioxi-
dant, anticancer, antiviral, and anti-infl ammatory activities. The aim of this study was to determine the biological activity of the extract from leaves 
of kiwi in relation to cells of erythrocytes and lymphoma. This activity was determined by studying kiwi leaves extract anti-hemolytic, cytotoxic and an-
tiproliferative activity, and  its ability to change the physical properties of  the cell membrane and  inhibit multidrug resistance of mouse lymphoma 
cells. It was shown that the extract ingredients bound to the cells, caused changes in erythrocyte shape and slightly affected the granularity and size 
of lymphoma cells. They effectively protected the red blood cells from oxidative damage, but were not toxic to lymphoma cells and did not affect their 
multidrug resistance. The extract of kiwi leaves is an effective antioxidant but it does not exhibit cytotoxic activity. Therefore, it can be used in the pre-
vention of diseases, especially those related to oxidative stress.
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ological functions of RBCs depends on the nature of the oxida-
tive agent [Borst et al., 2000; Hale et al., 2011]. In our previous 
work we found that mini-kiwi leaves extract protects biologi-
cal membranes from oxidation induced by different physico-
chemical factors, i.e. UVB and UVC radiation, and the AAPH 
compound [Cyboran et  al., 2014]. This high antilipoperoxi-
dant activity is mainly associated with the  location of  these 
compounds in  the hydrophilic area of  the membrane, where 
they form a protective barrier against diffusion of free radicals. 
Moreover, literature data indicate that some polyphenolic com-
pounds can also effectively protect not only the lipids of bio-
logical membrane but also whole erythrocytes against oxidative 
damage [Fofi e et al., 2014; Senguttuvan et al., 2014]. Polyphe-
nols can also modify the shape of erythrocytes without showing 
cytotoxic effects [Bonarska-Kujawa et al., 2012; Suwalsky et al., 
2006]. Our earlier research has shown the  mini-kiwi leaves 
extract to be nontoxic in relation to erythrocytes and even to 
strengthen them in  operating under the  conditions of  os-
motic shock [Cyboran et al., 2014]. Therefore, the main aim 
of the present research was to determine whether polyphenolic 
compounds contained in  the extract from the  leaves of mini-
-kiwi have the ability to change erythrocyte shape and protect 
the cells from oxidative damage. 
The second very important direction for research on sub-
stances of plant origin is their use in the prevention and treat-
ment of cancer. Polyphenolic compounds, and  in particular 
procyanidins, show the ability to inhibit the growth of various 
tumor cell lines, among others pancreatic, lung and colorec-
tal cancer cells [Akhtar el al., 2009; Chung et al., 2012; Kaur 
et al., 2008; Zhao et al., 2013]. In addition, these compounds 
may also inhibit the  multidrug resistance of  tumor cells 
and increase effi cacy of cytostatics [Zhao et al., 2013]. Multi-
drug resistance (MDR) of human tumors is one of the major 
reasons for the failure of chemotherapy in refractory cancer 
patients. The  reversal of  MDR in  cancer cells can be  im-
proved by  the application of  chemotherapy in  combination 
with resistance modifi ers [Szabo & Molnar, 1998; Szabo 
et al., 2000]. Great numbers of natural plant compounds, in-
cluding procyanidins and kiwi fruit extract, have been shown 
to block the  P-glycoprotein activity [He et  al., 2009; Mo-
tohashi et  al., 2002]. It was found that grape procyanidins 
reversed the MDR effect in blood-brain barrier by blocking 
the function of P-gp [He et al., 2009] and strongly inhibited 
P-gp expression by blocking MDR1 gene transcription. They 
also increased the intracellular accumulation of the P-gp sub-
strate rhodamine-123  in A2780/T cells [Zhao et  al., 2013]. 
In  the  literature there is a  lack of  studies on anticancer/cy-
totoxic and  MDR-reversal activity of  phenolics contained 
in  the  leaves of  mini-kiwi. This prompted us to undertake 
a  study on the  infl uence of  kiwi leaves extract (contain-
ing large amount of bioactive procyanidins) on the survival 
and multidrug resistance of lymphoma L5178 cells. 
MATERIALS AND METHODS
Plant material
Mini-kiwi leaves (Actinidia arguta, family Actinidia-
ceae, type: vine) extract was obtained from the Department 
of Fruit, Vegetable and Plant Nutraceutical Technology, Wro-
claw University of Environmental and Life Sciences, Poland. 
The Garden of Medicinal Plants herbarium of  the Medical 
University in Wroclaw, Poland, was the provider of kiwi leaves 
used in  the study. The research material was obtained from 
the stolon using a knife, and liquid nitrogen was used to freeze 
the leaves; and a dryer (Alpha 1–4 LSC, Christ, Germany) to 
freeze-dry them for 24 h. The procedure for obtaining a poly-
phenolic extract from the  leaves of mini kiwi and a detailed 
analysis of the composition of the extract were published ear-
lier in the work by Cyboran et al. [2014]. 
Cells and other compounds of interest
The study was conducted on pig erythrocytes and L5178 
mouse lymphoma T cells. The choice of pig erythrocytes was 
dictated by  the  fact that this cell’s percentage share of  lipids 
is closest to that of the human erythrocyte, and the blood was 
easily available. The choice of L5178 mouse lymphoma T cells 
was dictated by the fact that these cells are commonly used to 
study antitumor and MDR- reversal activity of chemicals.
The L5178 mouse lymphoma T cells (ECACC cat. no. 
87111908; U.S. FDA, Silver spring, MD, USA) were treated 
as a model of cancer cells. The cells were cultured in McCoy’s 
5A medium supplemented with L-glutamine and antibiotics 
(penicillin/streptomycin solution) at 37°C and  in  an atmo-
sphere with 5% CO2. The reagents for cell culture were pur-
chased from Sigma Aldrich (Steinheim, Germany).
The  oxidation inducer 2,2’-azobis(2-amidinopropane) 
dihydrochloride (AAPH) and  antioxidant standard L(+) 
ascorbic acid (AA) were purchased from Sigma-Aldrich, 
Inc., Steinheim, Germany. Verapamil and  3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were 
purchased from Sigma-Aldrich Quimica SA, Madrid, Spain. 
Procyanidin B3 was obtained from the Department of Fruit, 
Vegetable and Cereal Technology, Wroclaw University of En-
vironmental and  Life Sciences, Poland, and  was extracted 
from pine. All other reagents were analytically pure.
Spectrophotometric assay for anti-hemolytic activity
To test the effect of extract on hemolysis induced by free 
radicals, RBCs were pre-incubated with varying concen-
trations of  the  extract (1–8  μg/mL) dissolved in  ethanol at 
37°C for 1 h. In order to compare the anti-hemolytic activ-
ity of  the extract with other substances the RBCs were also 
incubated, in  the  same conditions, with procyanidin B3 
(1–8  μg/mL) and  L(+) ascorbic acid (1–40  μg/mL) dis-
solved in ethanol. Hemolysis of RBCs was carried out by mix-
ing a  3% suspension of  RBCs (unmodifi ed or modifi ed) 
in a phosphate buffer (pH=7.4) with AAPH solution (fi nal 
concentration 40 mmol/L). This reaction mixture was incu-
bated at 37°C for 3  h. After incubation, the  samples were 
centrifuged at 23°C (2000×g) for 15 min. The extent of he-
molysis was determined spectrophotometrically by measuring 
the absorbance of the supernatant at 540 nm. For reference, 
RBCs were treated with redistilled water and the absorbance 
of the hemolysate was used as 100% hemolysis. The percent-
age of  hemolysed cells was calculated as the  ratio of  ab-
sorbance of  extract’s modifi ed and AAPH oxidized cells to 
the absorbance of unmodifi ed and AAPH oxidized cells (con-
trol). The  IC50  value of  extract, responsible for 50% inhibi-
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tion of hemolysis induced by AAPH, was determined and was 
compared with IC50 values determined for standard antioxi-
dant L(+) ascorbic acid and procyanidin B3.
Microscopic studies of erythrocyte shapes
The impact of the extract on the shape of erythrocytes was 
determined by  using the  optical microscope and  scanning 
electron microscope (SEM).
After separating from plasma, the red cells were washed 
four times in a 0.9% NaCl solution in order to study them 
with the optical microscope. Next, the erythrocyte solution at 
2% hematocrit was incubated with kiwi leaves extract used at 
0.01 and 0.1 mg/mL for 1 h at 37°C. After this modifi cation, 
a 0.2% solution of glutaraldehyde was added to the erythro-
cytes to fi x them. The red cells thus prepared were observed 
under a biological optical microscope (Nikon Eclipse E200) 
equipped with a digital camera. On the basis of the obtained 
photographs, the percentage of the two basic forms, i.e. echi-
nocytes and stomatocytes, in a population of ca. 800 cells was 
specifi ed. Individual forms of erythrocyte cells were ascribed 
morphological indices according to the  Bessis scale [Ber-
nhardt & Ellory, 2003; Bessis, 1997]. Negative values from 
–1  to –4 were ascribed for stomatocytes and  positive ones 
from 1 to 4 for echinocytes.
For study with the electron microscope the erythrocytes 
were prepared in a way similar to that of optical microscope 
but slightly modifi ed. After incubating the erythrocytes with 
the extract, the cells were fi xed in a 2.5% solution of glutar-
aldehyde for 48 h. Next, the phosphate buffer was used for 
washing the cells for 20 min, followed by a rising series of ace-
tone concentrations (30, 50, 60, 70, 80, 90 and 100%) in order 
to dehydrate the cells. Every sample was washed for 15 min 
in a proper concentration of acetone, and next left in pure 
acetone for 30 min. After that, red cells were dried at 23°C 
for 12 h. The prepared cells were deposited on object stages 
and subjected to X-ray microanalysis by means of an X-ray 
analyzer (Brucker AXS Quantax) combined with the ESPRIT 
ver. 1.8.2. software. The  Scancoat 6 (Edwards, London) 
sprinkler was used to coat the samples with gold. To analyze 
material ultrastructure, we used a scanning microscope (EVO 
LS15 ZEISS) with SE1 detector, under high vacuum and ac-
celerating voltage of EHT=20 kV.
Spectrophotometric assays for cytotoxic and 
antiproliferative activities – MTT test
The antiproliferative and  toxic activity of  the kiwi leaves 
extract in  relation to mouse lymphoma T-cells were deter-
mined in  MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide) assays. The cells 6×103/well for anti-
proliferative assay or 2×104/well for cytotoxic assay in 50 μL 
of  the medium were added into 96-well, fl at-bottom culture 
plates. Next, the  extract dissolved in  ethanol (10  mg/mL) 
and diluted in 100  μL of  the  culture medium of  increasing 
concentrations from 1 to 400 μg/mL were added to the cells 
which were further incubated at 37°C for 72 h and 24 h for 
antiproliferative and cytotoxic assay, respectively. At the end 
of  the  incubation period, 15 μL of 5 mg/mL MTT solution 
were added to each well and the cells were incubated at 37°C 
for 4 h. After incubation, 100 μL of sodium dodecyl sulfate 
(10% SDS in 0.01 mol.L HCl) were added and the plates were 
further incubated overnight. The cell growth was then deter-
mined spectrophotometrically by measuring the absorbance 
at 550 nm (ref. 630 nm) with a Multiscan EX ELIXA reader 
(ThermoLabsystem, Cheshire, WA, USA). Inhibition of cell 
growth (Icg) was determined according to the formula:
Icg = × 100%
Acell modified – Amedium modified
Acell control – Amedium
Flow cytometry assay for reversal of  MDR in  mouse 
lymphoma cells
The impact of the extract on MDR reversal was determined 
by  treating the  mouse lymphoma L5178Y cells transfected 
with the  human MDR1  gene with different concentrations 
of kiwi leaves extract. The rhodamine-123 accumulation test 
was used. In general, the pHa MDR1/A retrovirus was used to 
infect the L5178 mouse T-lymphoma cells. By way of cultur-
ing the infected cells with 60 ng/mL colchicine, the MDR-1-ex-
pressing cell lines were obtained. Both MDR and PAR (parent) 
were grown in McCoy’s 5A medium with 10% heat-inactivated 
horse serum supplemented with L-glutamine and  antibi-
otics (penicillin/streptomycin solution). The  fi nal density 
of the cells in the samples was 2×106/mL, and they were re-
suspended in the serum-free McCoy’s 5A medium and distrib-
uted in 0.5 mL aliquots into the Eppendorf centrifuge tubes. 
Next, to the cell solutions the kiwi extract (dissolved in ethanol) 
was added, to the fi nal concentrations of 40 and 400 μg/mL, 
and the cells were incubated for 10 min at room temperature. 
Verapamil, treated as a standard MDR modulator, was used 
as a positive control. Next, the cells were incubated with 10 μL 
(5.2 μmol/L fi nal concentration) of rhodamine 123 (an indica-
tor) for further 20 min at 37°C, washed twice and re-suspend-
ed in 0.5 mL phosphate buffered saline (PBS) for analysis. 
A fl ow cytometer (Beckton-Dickinson FACS scan) was used to 
measure the light scattering and fl uorescence of the cell popu-
lation. On the basis of the obtained results the forward scatter 
count (FCS) and side scatter count (SSC) that depend on size, 
shape and optical homogeneity of the cells were determined. 
Furthermore, the percentages of the control mean fl uorescence 
intensity were calculated for MDR and parental (PAR) cells as 
compared with untreated cells. The fl uorescence activity ratio 
(FAR) was calculated from the measured fl uorescence values 





Statistical analysis of results was performed using the STA-
TISTICA 12.0 (StatSoft PL) software. For results obtained 
from microscopic and  anti-hemolytic tests, the  statistical 
analysis was conducted using the Dunnett test (post-hoc test 
– ANOVA) at a signifi cance level α=0.01 or α=0.05. Statisti-
cal analysis of results obtained from studies with lymphoma 
cells was conducted using Student’s t-test with the accepted 
level of signifi cance at α=0.05. All the experiments were done 
in at least three replicates, the results being presented as mean 
± standard deviation.
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RESULTS AND DISCUSSION 
The extract was prepared from the leaves of Actinidia ar-
gute obtained from the Garden of Medicinal Plants herbari-
um of the Medical University in Wroclaw, Poland. The con-
tent of  phenolic substances in  the  extract was analyzed 
by  using liquid chromatography UPLC/DAD and  UPLC/
ESI/MS methods and  is  ca. 600 mg in  1  g of  preparation 
[Cyboran et al., 2014]. The main polyphenolic components 
of the extract include different phenolic acids (neochlorogenic 
and chlorogenic acid, cryptochlorogenic), catechin, quercetin 
and kaempferol glycosides and, in particular, the B-type pro-
cyanidin dimers of high biological activity which constitute 
ca. 25% of the identifi ed polyphenolic compounds. 
Spectrophotometric assay for anti-hemolytic activity
By using spectrophotometric methods, the  anti-hemolytic 
activity of the extract was determined on the basis of the con-
centration of hemoglobin released from cells damaged by oxi-
dation. The obtained results showed that kiwi leaves extract ef-
fectively protects erythrocytes against the adverse effects of free 
radicals, because a concentration-dependent decrease in hemo-
lysis of erythrocytes was observed (Figure 1). Procyanidin B3 – 
one of the most active extract constituents, and L (+) ascorbic 
acid – the standard hydrophilic antioxidant, were included into 
this investigation. The IC50 value of kiwi leaves extract, procyan-
idin B3, and L (+) ascorbic acid responsible for 50% inhibition 
of AAPH-induced hemolysis of  erythrocytes were as follows: 
6.89±0.64, 2.50±0.12  and  32.57±1.16  μg/mL, respectively. 
The  results indicate that procyanidin B3  better protects cells 
from damage induced by free radicals than the extract, but both 
the  extract and procyanidin B3 are much more effective than 
the standard hydrophilic antioxidant which is ascorbic acid. 
Similar results, i.e. higher activity of procyanidin B3 than 
that of the extract, were observed in our previous work, where 
we examined the antilipoperoxidant activity of kiwi leaves ex-
tract and procyanidin B3 [Cyboran et al., 2014]. Furthermore, 
B type procyanidin dimers constitute about 25% of  extract 
ingredients [Cyboran et al., 2014]. Therefore, to establish if 
activity of procyanidin is modifi ed by other extract compo-
nents, we compared the  activity of  procyanidin B3  used at 









































FIGURE 1. Percentage of hemolysed cells vs. concentration of kiwi leaves 
extract and  its constituent procyanidin B3. Statistical analysis was con-
ducted using the Dunnett test. Statistically signifi cant results are denoted, 
respectively: *α=0.05, **α=0.01.
FIGURE 2. Shapes of unmodifi ed erythrocytes (A) and those modifi ed 
with kiwi leaves extract used at the  concentration of  0.01 mg/mL (B) 
and 0.1 mg/mL (C), observed with an electron microscope.
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at 8  μg/mL (the  same procyanidin concentration). The  re-
sults included in Figure 1  clearly indicate that procyanidin 
B3 in the extract better protects erythrocytes against oxidative 
damage than when used alone. The obtained results confi rm 
that biological activity, in particular antioxidant/anti-hemo-
lytic activity, of the extract depends not only on the number, 
amount, and  type of  its constituents but also on their mu-
tual interaction. Hence extract components, by  preserving 
whole erythrocytes and their membrane phospholipids intact, 
and due to their anti-hemolytic and antilipoperoxidant activ-
ity, may maintain in  vivo the  integrity of RBC in capillaries 
and effectively counteract free radical damage.
Microscopic studies of erythrocyte shapes
To determine the  location of  extract constituents 
in  the  erythrocyte membrane, their impact on the  shape 
of erythrocytes was examined. The study was conducted us-
ing an electron and optical microscope, coupled with a digi-
tal camera. Sample photographs of  the blood cells (control 
and extract’s modifi ed) taken with the electron microscope are 
shown in Figures 2 (A), (B) and (C).
The photographs registered by using the optical micro-
scope allow to quantify the  individual forms of erythrocytes 
in  a  population of  800  cells. The  classifi cation of  shapes 
was carried out based on the scale of Bessis & Brecher [Ber-
nhardt & Ellory, 2003; Bessis, 1997], where specifi c shapes 
are assigned the  following morphological indexes: sphero-
stomatocytes (-4), stomatocytes II (-3), stomatocytes I (-2), 
discostomatocytes (-1), discocytes (0), discoechinocytes 
(1), echinocytes (2), spheroechinocytes (3), and  sphero-
cytes (4). Figure 3  shows the percentage of  specifi c shapes 
of  erythrocytes modifi ed with the  kiwi leaves extract at 
0.01 and 0.1 mg/mL concentrations. 
The obtained results have shown that erythrocytes modi-
fi ed by  the  extract used at 0.01  mg/mL practically do not 
differ from control cells. At a  higher extract concentration 
(0.1 mg/mL) a decrease were observed in the number of dis-
cocites and  increase in  the  number of  discoechinocytes (1) 
and  echinocytes (2). The  formation of  echinocytes means, 
according to the Sheetz and Singer theory [Sheetz & Singer, 
1974], that extract components may bind only to the outer 
monolayer of  erythrocyte membrane. Our earlier studies 
showed changes in  membrane fl uidity and  packing order 
of  the  polar heads of  lipids of  the  erythrocyte membrane 
caused by a mini-kiwi leaves extract [Cyboran et  al., 2014]. 
Literature data indicate that various phenolic extracts and free 
phenolic compounds, that are able to modulate the  hydro-
philic and hydrophobic parts of  erythrocyte membrane, can 
induce changes in erythrocyte shape [Bonarska-Kujawa et al., 
2015; Suwalsky et  al., 2007], this being in  good agreement 
with our results. The main extract ingredients, like procyanidin 
B3 or chlorogenic acid, used at the same concentration as that 
in the extract, induce the formation of echinocytes to a much 
greater extent (results not included). Taking into account this 
result, the slight induction of echinocytes caused by the extract 
is probably due to the presence of other compounds which 
have a lower affi nity to the membrane. It is possible, because 
among the  polyphenolic components of  the  extract, aside 
of monomers and procyanidin dimers which are readily identi-
fi ed by HPLC methods, there might also occur procyanidin 
oligomers which have been detected in, e.g., a hydroalcoholic 
extract from plants of the Actinidia family [Pinelli et al., 2013]. 
Due to their size, such components are not expected to pen-
etrate deep into the membrane but can interact with its sur-
face. The presence of such compounds can also impair bind-
ing of other compounds which exhibit that ability, i.e. B type 
procyanidins or phenolic acids, to the membrane.
MTT cytotoxicity assay
The in vitro research on antiproliferative and toxic activity 
of the kiwi leaves extract in relation to the mouse lymphoma 
cell line was done by using an MTT assay. The results of both 
experiments (24 and 72 h) are shown in Table 1. The optical 
density of cancer cells in  the presence of 1–400 μg/mL kiwi 
extract was from 0.512 to 0.485 after 24 h and from 0.612 to 
0.694 after 72 h, respectively, whereas the values determined 



































FIGURE 3. Mean percentage of erythrocyte shapes formed in the pres-
ence of kiwi leaves extract applied at 0.01 mg/mL and 0.1 mg/mL. Statis-
tical analysis was conducted using the Dunnett test. Statistically signifi -
cant results are denoted, respectively: *α=0.05, **α=0.01. 
TABLE 1. Optical density of cancer cells non-treated (control) and incu-
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0.630 after 72 h. The inhibition of cells grown (Icg) calculated 
on the basis of these results was less than 2% and indicated 
that, in the applied concentrations, the compounds contained 
in the extract had no antiproliferative and cytotoxic effect on 
mouse lymphoma cells. 
Assay for the reversal of MDR in mouse lymphoma cells
The effects of the extract on reversion of multidrug resis-
tance in the L5178Y mouse T-cell lymphoma drug-sensitive 
(parent) and  multidrug resistant (MDR) cells were exam-
ined. The well-known MDR modifi er verapamil was used as 
a  control. The  reversal effect was determined on the basis 
of  the  calculated fl uorescence activity ratio (FAR) between 
treated and untreated groups of cells. The kiwi extract was 
ineffective at both applied concentrations, because the FAR 
values calculated for the extract-modifi ed cells were less than 
MDR means and also several times lower than the values cal-
culated for verapamil-treated cells (Table 2). It means that 
the extract was ineffective as a resistance modifi er of lympho-
ma cells. However, the slightly increased values of side scatter 
count (SSC is proportional to cell granularity) and slightly 
decreased values of  forward scatter count (FCS) obtained 
for the extract-modifi ed cells compared to the control (Ta-
ble 2) may refer to some non-specifi c membrane effects.
This research has shown that the kiwi leaves extract, de-
spite the  high content of  procyanidins and  other phenolic 
compounds, is  ineffective as a  resistance modifi er of  lym-
phoma cells, because its ingredients have no inhibitory effect 
of P-glycoprotein. However, this result indicates that the ex-
tract can interact with lymphoma cells in an unspecifi c way, 
because it caused a slight change in cell granularity and cell 
size. However, this observation requires more accurate and de-
tailed research. This study proves that the well-documented 
anticancer/cytotoxic activity of procyanidins strongly depends 
on mutual interaction between them and  other phenolic 
compounds, when present in a mixture and also on the type 
of cancer cells. In future studies, the fraction of procyanidins 
should be isolated from the kiwi leaves extract and their bio-
logical activity examined in order to determine the suitability 
of  those compounds, not only in  the prevention of diseases 
but also in the treatment of cancer cells.
CONCLUSION
Kiwi leaves extract has high anti-hemolytic activity 
and ability to modulate the physical properties of the cells. 
The  extract effectively protects erythrocytes from oxida-
tive damage caused by water-soluble free radicals. Its in-
gredients bind to the  cell membrane, change its physical 
properties, inducing alteration in the shape of erythrocytes, 
and slightly affect granularity and size of  lymphoma cells. 
Owing to the binding they may form a barrier on the mem-
brane which protects against the harmful effect of free radi-
cals. On the other hand, the B type procyanidins contained 
in a large amount in the extract, of documented anticancer 
activity, are nontoxic and do not exhibit the antiprolifera-
tive activity with respect to lymphoma cells and do not af-
fect their multidrug resistance. The extract from the leaves 
of the kiwi may fi nd an application in the prevention of dis-
eases especially those caused by  the oxidative stress. Fur-
thermore, it may be a useful material for obtaining procy-
anidins, which after further research may prove effective 
against tumor cells, as it has been in the case of procyani-
dins contained in kiwi fruit.  
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TABLE 2. Flow-cytometric analysis of the effect of Actinidia arguta leaf extract on rhodamine 123 accumulation of human MDR gene transfected 
mouse lymphoma cells.
Sample Concentration (μg/mL) FSCc SSCd Mean FARe
PARa – 1917 1688 94.7 –
MDRb – 2167 877 2.03 –
Verapamil 10 2077* 800* 33.6** 16.55
Kiwi leaf extract 40 2168 891 1.75 0.86
Kiwi leaf extract 400 2074** 1002* 2.76* 1.35
aparental cells without transfection of MDR1 gene; bparental cells transfected with MDR 1 gene; cFSC – forward scatter count (cell size ratio); dSSC – 
side scatter count; eFAR – fl uorescence activity ratio. 
*Statistical analysis was conducted using the Student’s t-test. Statistically signifi cant results are denoted, respectively: *p < 0.05, **p < 0.01.
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